Microbiome Space in Spotlight as Microbiotica Sets Funding Record
Competition is heating up in the microbiome niche as UK-based Microbiotica raised €60M (£50M) in…
March 11, 2022 - 3 minutes
Microbiome: An Emerging Field with Growing Investments
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Show More
Editor's Picks for Microbiome
- UK Startup Surfs Investment Wave in Microbiome with €18M Series A
- Microbiome Medicines Could Power Up CAR-T Cell Therapies
- Investing in the Microbiome in the Age of Covid-19 and Beyond
- The Missing Piece in the Microbiome Field
- No Guts, No Glory: How Microbiome Research is Changing Medicine
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportLatest Microbiome Articles
UK Startup Surfs Investment Wave in Microbiome with €18M Series A
As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series…
September 15, 2021 - 4 minutes
Microbiome Medicines Could Power Up CAR-T Cell Therapies
The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings…
July 28, 2021 - 5 minutes
Scotland’s Top 10 Biotech Companies to Watch Out For
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
June 30, 2021 - 11 minutes
Startup Creator Launched to Fill Europe’s Microbiome Translational Gap
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the…
May 28, 2021 - 6 minutes
GSK Acne Deal Heralds Growing Interest in Skin Microbiome
This week, the Paris-based Eligo Bioscience became one of a growing number of biotechs to…
January 15, 2021 - 4 minutes
Microbiome Therapies Threatened by Covid-19 Restrictions
Providers of microbiome therapies worldwide have been hit by pandemic restrictions on the harvest of…
September 1, 2020 - 5 minutes
Enterome Secures €46M to Take Microbiome Therapies to Clinical Trials
French microbiome biotech Enterome has raised €46.3M in Series E funding to progress its cancer…
June 29, 2020 - 3 minutes
French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders
The microbiome company LNC Therapeutics has entered into a licensing agreement to use a specific…
April 17, 2020 - 3 minutes
Investing in the Microbiome in the Age of Covid-19 and Beyond
For Isabelle de Cremoux, CEO and Managing Partner at Seventure Partners, 2020 was going to…
April 15, 2020 - 7 minutes
Charcoal-Based Treatment Can Protect Gut Microbiome from Antibiotics
Ingestible pellets containing a charcoal-like treatment -- designed by the French company Da Volterra --…
February 12, 2020 - 2 minutes
MaaT Pharma’s Microbiome Cancer Treatment Given €18M Boost
French company MaaT Pharma has raised €18M in Series B financing that will support phase…
February 5, 2020 - 3 minutes
